Sign in
4

Changes in Ownership

CG Oncology, Inc. Filed Acc 0001415889-24-002062

10% owner bought 400,000 shares at $19.00 ($7,600,000)

  • 10% owner acquired 3,628,198 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Decheng Capital Global Life Sciences Fund IV, L.P. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-29 Conversion : show line 1 in the form +3,628,198 4,558,812 D
2024-01-29 Purchase : show line 2 in the form +400,000 $19.00 $7,600,000 400,000 I
Open-market purchases · 400,000 sh · avg $19.00 · $7,600,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-01-29 Conversion : show line 3 in the form Series C Preferred Stock −8,644,891 0 D
2024-01-29 Conversion : show line 4 in the form Series E Preferred Stock −21,547,685 0 D
2024-01-29 Conversion : show line 5 in the form Series F Preferred Stock −4,402,320 0 D
Loading xslF345X05/form4-01312024_090105.xml…